A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers
Clinical trial NCT05023525 · COMPLETED
Trial details
- NCT number
- NCT05023525
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2022-04-19
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.